Clinical Trials Directory

Trials / Completed

CompletedNCT04622683

Effects of Hepatic Ultrasound on Metabolic Homeostasis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
37 (actual)
Sponsor
Yale University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to define the effect of ultrasound exposure of the liver in the region of the porta hepatis on glucose homeostasis and insulin resistance in healthy subjects.

Conditions

Interventions

TypeNameDescription
PROCEDUREUltrasoundTo determine whether ultrasound exposure at the porta hepatis will affect plasma glucose levels. To also determine whether porta hepatic ultrasound exposure will affect plasma glucose levels as well as insulin sensitivity among overweight/obese individuals who have normal glucose tolerance or impaired glucose tolerance (as defined by OGTT.

Timeline

Start date
2021-01-01
Primary completion
2023-09-13
Completion
2023-09-13
First posted
2020-11-10
Last updated
2024-12-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04622683. Inclusion in this directory is not an endorsement.

Effects of Hepatic Ultrasound on Metabolic Homeostasis (NCT04622683) · Clinical Trials Directory